3886.HK
HoldUnloved QualityTown Health International Medical Group Limited · Healthcare · Hong Kong · $149M · Avg Vol: $13K/d
Unloved Quality: Strong and cheap, but the market has not turned yet. Patience required.
ABOUT TOWN HEALTH INTERNATIONAL MEDICAL GROUP LIMITED
Read
Town Health International Medical Group Limited, an investment holding company, provides healthcare and related services in the People's Republic of China and Hong Kong.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.8B | 1.8B | 1.8B | 5.2% | 1.8B |
| EPS (HKD) | 0.00 | -0.03 | -0.03 | 0.00 | 0.0% | — |
| Shares | 6.8B | 6.8B | 6.8B | 6.8B | -0.9% | 6.8B |
| Debt | 475.0M | 456.9M | 319.6M | 147.6M | -32.3% | 189.5M |
| Equity | 3.5B | 3.2B | 3.0B | 3.0B | -5.0% | — |
| Op CF | 43.0M | 247.5M | 244.8M | 147.1M | 50.6% | 147.1M |
| Inv CF | 587.8M | -20.9M | 164.3M | 113.3M | — | — |
| Fin CF | -529.7M | -151.1M | -235.7M | -280.9M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3886.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3886.HK | Town Health International Medical Group Limited(you) | $149M | 47 | Hold |
| 0648.HK | SoftMedx Healthcare Limited | $83M | 62 | Hold |
| 3309.HK | C-MER Medical Holdings Limited | $129M | 82 | Strong Buy |
| 2138.HK | EC Healthcare | $61M | 75 | Buy |
| 1830.HK | Perfect Medical Health Management Limited | $210M | 100 | Strong Buy |
| 2189.HK | Kato (Hong Kong) Holdings Limited | $63M | 97 | Strong Buy |
| 0419.HK | Hony Media Group | $130M | 30 | Sell |
| 3681.HK | SinoMab BioScience Limited | $190M | 8 | Strong Sell |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $101M | 84 | Strong Buy |
| 2161.HK | JBM (Healthcare) Limited | $192M | 89 | Strong Buy |
Peer medians: ROE 6.5% · P/E 10.5x · Gross margin 42.1%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.